How has been the historical performance of Medplus Health?

Answer:The historical performance of Medplus Health shows significant growth in net sales and profitability over the years, culminating in the fiscal year ending March 2025.

Breakdown:
Medplus Health has demonstrated a consistent upward trend in net sales, increasing from 2,870.60 Cr in March 2020 to 6,136.05 Cr in March 2025. This growth is reflected in total operating income, which rose from 2,870.60 Cr in March 2020 to 6,136.05 Cr in March 2025. Total expenditure also increased, reaching 5,648.95 Cr in March 2025, but the operating profit (PBDIT) saw a substantial rise to 535.72 Cr, up from 150.96 Cr in March 2020. Profit before tax improved significantly from 29.36 Cr in March 2020 to 183.29 Cr in March 2025, while profit after tax also rose to 150.23 Cr from just 1.79 Cr in March 2020. The earnings per share (EPS) increased from 50.99 in March 2020 to 12.56 in March 2025, indicating enhanced shareholder value. On the balance sheet, total assets grew from 1,308.54 Cr in March 2020 to 3,260.27 Cr in March 2025, with total liabilities also increasing to 3,260.27 Cr. Cash flow from operating activities improved significantly, reaching 540.00 Cr in March 2025, compared to a negative cash flow of 6.00 Cr in March 2020. Overall, Medplus Health's financial performance reflects strong growth and operational efficiency over the years.